Finance

Lists
Why is 603456 up 3.01%?
Dive Deeper
603456:SHA
Zhejiang Jiuzhou Pharmaceutical Co Ltd
CN¥16.75
+3.01%
(+0.49) 1D
Sep 30, 3:00:02 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 603456...
Open
CN¥16.25
High
CN¥16.95
Low
CN¥16.16
Mkt. cap
14.67B
Avg. vol.
23.68M
Volume
26.63M
Dividend
1.19%
Quarterly dividend
CN¥0.05
Ex-dividend date
Sep 11, 2026
P/E ratio
25.12
52-wk high
CN¥22.25
52-wk low
CN¥12.05
EPS
CN¥0.67
Shares outstanding
805.89M
No. of employees
5K
Open
CN¥16.25
High
CN¥16.95
Low
CN¥16.16
Mkt. cap
14.67B
Avg. vol.
23.68M
Volume
26.63M
Dividend
1.19%
Quarterly dividend
CN¥0.05
Ex-dividend date
Sep 11, 2026
P/E ratio
25.12
52-wk high
CN¥22.25
52-wk low
CN¥12.05
EPS
CN¥0.67
Shares outstanding
805.89M
No. of employees
5K
News stories
From web sources and news partners
About Zhejiang Jiuzhou Pharmaceutical Co Ltd
CEO-
Employees4.79K
Founded1973
Headquarters-
SectorPharmaceutical industry
Websitejiuzhoupharma.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.29B
1.35B
1.20B
1.37B
Cost of goods sold
761.49M
1.05B
763.95M
887.73M
Cost of revenue
761.49M
1.05B
763.95M
887.73M
Research and development expenses
66.69M
62.23M
56.24M
73.35M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
121.40M
134.09M
131.90M
127.21M
Operating expense
182.22M
220.80M
199.95M
220.47M
Total operating expenses
943.71M
1.27B
963.90M
1.11B
Operating income
345.83M
79.57M
236.76M
266.38M
Other non operating income
-6.55M
7.81M
-12.27M
11.69M
EBT including unusual items
259.49M
9.64M
219.86M
265.57M
EBT excluding unusual items
356.56M
81.56M
234.29M
262.63M
Income tax expense
37.43M
29.78M
51.59M
53.15M
Effective tax rate
14.43%
308.74%
23.46%
20.01%
Other operating expenses
7.29M
18.43M
8.30M
16.03M
Net income
221.82M
-17.58M
172.08M
215.31M
Net profit margin
17.20%
-1.30%
14.33%
15.66%
Earnings per share
-
-
-
-
Interest and investment income
16.47M
11.44M
11.16M
11.93M
Interest expense
-1.58M
-4.34M
-1.35M
-1.12M
Net interest expenses
14.89M
7.09M
9.80M
10.81M
Depreciation and amortization charges
-
-
-
-
EBITDA
444.34M
181.68M
338.87M
374.56M
Gain or loss from assets sale
-1.86M
5.16M
-
2.80M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps